Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1994 Aug;72(2 Suppl):S18–S21. doi: 10.1136/hrt.72.2_suppl.s18

Central haemodynamic expressions of heart failure

Felix Burkart 1
PMCID: PMC1025568  PMID: 7946751

Full text

PDF
S18

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong P. W., Stopps T. P., Ford S. E., de Bold A. J. Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure. Circulation. 1986 Nov;74(5):1075–1084. doi: 10.1161/01.cir.74.5.1075. [DOI] [PubMed] [Google Scholar]
  2. Aronson R. S. Characteristics of action potentials of hypertrophied myocardium from rats with renal hypertension. Circ Res. 1980 Sep;47(3):443–454. doi: 10.1161/01.res.47.3.443. [DOI] [PubMed] [Google Scholar]
  3. Bayliss J., Canepa-Anson R., Norell M. S., Poole-Wilson P., Sutton G. Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise. Br Heart J. 1986 Mar;55(3):265–273. doi: 10.1136/hrt.55.3.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bertel O., Burkart F., Bühler F. R. Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure. Am Heart J. 1981 May;101(5):529–533. doi: 10.1016/0002-8703(81)90217-9. [DOI] [PubMed] [Google Scholar]
  5. Bristow M. R., Ginsburg R., Umans V., Fowler M., Minobe W., Rasmussen R., Zera P., Menlove R., Shah P., Jamieson S. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res. 1986 Sep;59(3):297–309. doi: 10.1161/01.res.59.3.297. [DOI] [PubMed] [Google Scholar]
  6. Chatterjee K., Parmley W. W., Ganz W., Forrester J., Walinsky P., Crexells C., Swan H. J. Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation. 1973 Dec;48(6):1183–1193. doi: 10.1161/01.cir.48.6.1183. [DOI] [PubMed] [Google Scholar]
  7. Cohn J. N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W. B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303–310. doi: 10.1056/NEJM199108013250502. [DOI] [PubMed] [Google Scholar]
  8. Cooper G., 4th Cardiocyte adaptation to chronically altered load. Annu Rev Physiol. 1987;49:501–518. doi: 10.1146/annurev.ph.49.030187.002441. [DOI] [PubMed] [Google Scholar]
  9. Cooper G., 4th, Kent R. L., Uboh C. E., Thompson E. W., Marino T. A. Hemodynamic versus adrenergic control of cat right ventricular hypertrophy. J Clin Invest. 1985 May;75(5):1403–1414. doi: 10.1172/JCI111842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cooper G., 4th, Marino T. A. Complete reversibility of cat right ventricular chronic progressive pressure overload. Circ Res. 1984 Mar;54(3):323–331. doi: 10.1161/01.res.54.3.323. [DOI] [PubMed] [Google Scholar]
  11. Cooper G., 4th, Satava R. M., Jr, Harrison C. E., Coleman H. N., 3rd Mechanisms for the abnormal energetics of pressure-induced hypertrophy of cat myocardium. Circ Res. 1973 Aug;33(2):213–223. doi: 10.1161/01.res.33.2.213. [DOI] [PubMed] [Google Scholar]
  12. Curtiss C., Cohn J. N., Vrobel T., Franciosa J. A. Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure. Circulation. 1978 Nov;58(5):763–770. doi: 10.1161/01.cir.58.5.763. [DOI] [PubMed] [Google Scholar]
  13. Dzau V. J., Colucci W. S., Hollenberg N. K., Williams G. H. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation. 1981 Mar;63(3):645–651. doi: 10.1161/01.cir.63.3.645. [DOI] [PubMed] [Google Scholar]
  14. Ehrsam R. E., Perruchoud A., Oberholzer M., Burkart F., Herzog H. Influence of age on pulmonary haemodynamics at rest and during supine exercise. Clin Sci (Lond) 1983 Dec;65(6):653–660. doi: 10.1042/cs0650653. [DOI] [PubMed] [Google Scholar]
  15. Feldman M. D., Copelas L., Gwathmey J. K., Phillips P., Warren S. E., Schoen F. J., Grossman W., Morgan J. P. Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation. 1987 Feb;75(2):331–339. doi: 10.1161/01.cir.75.2.331. [DOI] [PubMed] [Google Scholar]
  16. Fink L. I., Wilson J. R., Ferraro N. Exercise ventilation and pulmonary artery wedge pressure in chronic stable congestive heart failure. Am J Cardiol. 1986 Feb 1;57(4):249–253. doi: 10.1016/0002-9149(86)90900-8. [DOI] [PubMed] [Google Scholar]
  17. Flaim S. F., Minteer W. J. Ventricular volume overload alters cardiac output distribution in rats during exercise. J Appl Physiol Respir Environ Exerc Physiol. 1980 Sep;49(3):482–490. doi: 10.1152/jappl.1980.49.3.482. [DOI] [PubMed] [Google Scholar]
  18. Fowler M. B., Laser J. A., Hopkins G. L., Minobe W., Bristow M. R. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation. 1986 Dec;74(6):1290–1302. doi: 10.1161/01.cir.74.6.1290. [DOI] [PubMed] [Google Scholar]
  19. Francis G. S., Goldsmith S. R., Levine T. B., Olivari M. T., Cohn J. N. The neurohumoral axis in congestive heart failure. Ann Intern Med. 1984 Sep;101(3):370–377. doi: 10.7326/0003-4819-101-3-370. [DOI] [PubMed] [Google Scholar]
  20. Gerbes A. L., Arendt R. M., Schnizer W., Silz S., Jüngst D., Zähringer J., Paumgartner G. Regulation of atrial natriuretic factor release in man: effect of water immersion. Klin Wochenschr. 1986 Jul 15;64(14):666–667. doi: 10.1007/BF01726920. [DOI] [PubMed] [Google Scholar]
  21. Hasking G. J., Esler M. D., Jennings G. L., Burton D., Johns J. A., Korner P. I. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986 Apr;73(4):615–621. doi: 10.1161/01.cir.73.4.615. [DOI] [PubMed] [Google Scholar]
  22. Jafri S. M., Lakier J. B., Rosman H. S., Goldstein S. Prevalence of congestion in chronic heart failure. Chest. 1986 Sep;90(3):311–312. doi: 10.1378/chest.90.3.311. [DOI] [PubMed] [Google Scholar]
  23. Keung E. C., Keung C. S., Aronson R. S. Passive electrical properties of normal and hypertrophied rat myocardium. Am J Physiol. 1982 Dec;243(6):H917–H926. doi: 10.1152/ajpheart.1982.243.6.H917. [DOI] [PubMed] [Google Scholar]
  24. Kiowski W., Drexler H., Meinertz T., Zuber M., Ritz R., Burkart F., Just H. Cilazapril in congestive heart failure. A pilot study. Drugs. 1991;41 (Suppl 1):54–61. doi: 10.2165/00003495-199100411-00010. [DOI] [PubMed] [Google Scholar]
  25. Konstam M. A., Rousseau M. F., Kronenberg M. W., Udelson J. E., Melin J., Stewart D., Dolan N., Edens T. R., Ahn S., Kinan D. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. Circulation. 1992 Aug;86(2):431–438. doi: 10.1161/01.cir.86.2.431. [DOI] [PubMed] [Google Scholar]
  26. Lambertz H., Meyer J., Erbel R. Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure. Circulation. 1984 Feb;69(2):298–305. doi: 10.1161/01.cir.69.2.298. [DOI] [PubMed] [Google Scholar]
  27. Leimbach W. N., Jr, Wallin B. G., Victor R. G., Aylward P. E., Sundlöf G., Mark A. L. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation. 1986 May;73(5):913–919. doi: 10.1161/01.cir.73.5.913. [DOI] [PubMed] [Google Scholar]
  28. Lipkin D. P., Canepa-Anson R., Stephens M. R., Poole-Wilson P. A. Factors determining symptoms in heart failure: comparison of fast and slow exercise tests. Br Heart J. 1986 May;55(5):439–445. doi: 10.1136/hrt.55.5.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lompre A. M., Schwartz K., d'Albis A., Lacombe G., Van Thiem N., Swynghedauw B. Myosin isoenzyme redistribution in chronic heart overload. Nature. 1979 Nov 1;282(5734):105–107. doi: 10.1038/282105a0. [DOI] [PubMed] [Google Scholar]
  30. Mathey D., Hanrath P., Polster J., Witte G., Montz R., Bleifeld W. Acute and chronic effects of oral hydralazine on left ventricular pump function and renal hemodynamics in chronic left heart failure. Eur Heart J. 1980 Feb;1(1):25–29. doi: 10.1093/oxfordjournals.eurheartj.a061091. [DOI] [PubMed] [Google Scholar]
  31. Meerson F. Z. The myocardium in hyperfunction, hypertrophy and heart failure. Circ Res. 1969 Jul;25(1 Suppl):1–163. [PubMed] [Google Scholar]
  32. Mercadier J. J., Bouveret P., Gorza L., Schiaffino S., Clark W. A., Zak R., Swynghedauw B., Schwartz K. Myosin isoenzymes in normal and hypertrophied human ventricular myocardium. Circ Res. 1983 Jul;53(1):52–62. doi: 10.1161/01.res.53.1.52. [DOI] [PubMed] [Google Scholar]
  33. Raine A. E., Erne P., Bürgisser E., Müller F. B., Bolli P., Burkart F., Bühler F. R. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med. 1986 Aug 28;315(9):533–537. doi: 10.1056/NEJM198608283150901. [DOI] [PubMed] [Google Scholar]
  34. Serizawa T., Mirsky I., Carabello B. A., Grossman W. Diastolic myocardial stiffness in gradually developing left ventricular hypertrophy in dog. Am J Physiol. 1982 Apr;242(4):H633–H637. doi: 10.1152/ajpheart.1982.242.4.H633. [DOI] [PubMed] [Google Scholar]
  35. Shenker Y., Sider R. S., Ostafin E. A., Grekin R. J. Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema. J Clin Invest. 1985 Oct;76(4):1684–1687. doi: 10.1172/JCI112154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sordahl L. A., McCollum W. B., Wood W. G., Schwartz A. Mitochondria and sarcoplasmic reticulum function in cardiac hypertrophy and failure. Am J Physiol. 1973 Mar;224(3):497–502. doi: 10.1152/ajplegacy.1973.224.3.497. [DOI] [PubMed] [Google Scholar]
  37. Spann J. F., Jr Heart failure and ventricular hypertrophy. Altered cardiac contractility and compensatory mechanisms. Am J Cardiol. 1969 Apr;23(4):504–510. doi: 10.1016/0002-9149(69)90003-4. [DOI] [PubMed] [Google Scholar]
  38. Wüsten B., Buss D. D., Deist H., Schaper W. Dilatory capacity of the coronary circulation and its correlation to the arterial vasculature in the canine left ventricle. Basic Res Cardiol. 1977 Nov-Dec;72(6):636–650. doi: 10.1007/BF01907044. [DOI] [PubMed] [Google Scholar]
  39. Yamaji T., Ishibashi M., Nakaoka H., Imataka K., Amano M., Fujii J. Possible role for atrial natriuretic peptide in polyuria associated with paroxysmal atrial arrhythmias. Lancet. 1985 May 25;1(8439):1211–1211. doi: 10.1016/s0140-6736(85)92883-1. [DOI] [PubMed] [Google Scholar]
  40. Yamaji T., Ishibashi M., Takaku F. Atrial natriuretic factor in human blood. J Clin Invest. 1985 Oct;76(4):1705–1709. doi: 10.1172/JCI112159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. de Bold A. J., Borenstein H. B., Veress A. T., Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 1981 Jan 5;28(1):89–94. doi: 10.1016/0024-3205(81)90370-2. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES